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Abstract
Background: We previously identified curcumin as a potent inducer of fibroblast apoptosis, which could be used to treat
hypertrophic scar formation. Here we investigated the underlying mechanism of this process.
Principal Findings: Curcumin-induced apoptosis could not be blocked by caspase-inhibitors and we could not detect any
caspase-3/7 activity. Curcumin predominantly induced mitochondria-mediated ROS formation and stimulated the
expression of the redox-sensitive pro-apoptotic factor p53. Inhibition of the pro-apoptotic signaling enzyme glycogen
synthase kinase-3b (GSK-3b) blocked curcumin-induced apoptosis. Apoptosis was associated with high molecular weight
DNA damage, a possible indicator of apoptosis-inducing factor (AIF) activity. Indeed, curcumin caused nuclear translocation
of AIF, which could be blocked by the antioxidant N-acetyl cysteine. We next investigated how AIF is effluxed from
mitochondria in more detail. The permeability transition pore complex (PTPC), of which the voltage-dependent anion
channel (VDAC) is a component, could be involved since the VDAC-inhibitor DIDS (4,49-diisothiocyanatostilbene-2,29-
disulfonic acid) efficiently blocked AIF translocation. However, PTPC is not involved in AIF release since cyclosporine A, a
specific inhibitor of the complex did not block apoptosis. Alternatively, the pro-apoptotic protein Bax could have formed
mitochondrial channels and interacted with VDAC. Curcumin caused mitochondrial translocation of Bax, which was blocked
by DIDS, suggesting a Bax-VDAC interaction. Interestingly, ceramide channels can also release apoptogenic factors from
mitochondria and we found that addition of ceramide induced caspase-independent apoptosis. Surprisingly, this process
could also be blocked by DIDS, suggesting the concerted action of Bax, VDAC and ceramide in the efflux of AIF from the
mitochondrion.
Conclusions: Curcumin-induced fibroblast apoptosis is totally caspase-independent and relies on the mitochondrial
formation of ROS and the subsequent nuclear translocation of AIF, which is released from a mitochondrial pore that involves
VDAC, Bax and possibly ceramides. The composition of the AIF-releasing channel seems to be much more complex than
previously thought.
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Introduction
We previously demonstrated that a high dose of curcumin
induces apoptosis in human dermal fibroblasts via the formation of
reactive oxygen species (ROS) [1]. This apoptotic activity of
curcumin is important, since it may be used to diminish scar
formation in patients with severe burns. Therefore, we investigated
the underlying molecular mechanism in more detail.
Apoptosis, also referred to as programmed cell death, is not only
an important mechanism involved in development and homeo-
static regulation but also plays a central role in several pathological
conditions such as cancer and fibrosis. Generally, apoptosis can
occur in either a caspase-dependent or -independent fashion. For
caspase-dependent apoptosis two major pathways have been
identified: the extrinsic pathway, which involves triggering of
death receptors like tumor necrosis factor (TNF) receptor, FAS/
CD95-APO-1 and TRAIL/APO-2, and the intrinsic pathway in
which the mitochondrion is the central regulator [2]. Fas-
associated death domain (FADD) and TNF-receptor-associated
death domain (TRADD) recruit and activate caspase-8 to form a
death-inducing signaling complex (DISC) [3]. DISC can propa-
gate the death signal generally in two ways. First, DISC can splice
Bid, which upon translocation to the mitochondria can cause
mitochondrial outer membrane permeabilization (MOMP), lead-
ing to the release of pro-apoptotic proteins, such as cytochrome c
[4]. Cytochrome c can interact with apoptotic protease activating
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complex is able to activate caspase 9, which in turn activates the
effector caspases 3, 6 and 7, leading to apoptosis [5]. Alternatively,
DISC can also directly activate these effector caspases [6].
The point-of-no-return for the intrinsic pathway is character-
ized by MOMP, which is controlled by the family of Bcl-2 proteins
[7]. These proteins are either anti- or pro-apoptotic and the
balance between these two groups ultimately determines cell
survival or cell death. The pro-apoptotic Bcl-2 family members
Bax and Bak probably contribute to MOMP by interacting with
the Permeability Transition Pore Complex (PTPC), which is
supposed to consist of the Voltage Dependent Anion Channel
(VDAC), Cyclophilin D (CypD) and adenine nucleotide translo-
case (ANT), and allows for the release of cytochrome c from the
mitochondrial intermembrane space [8,9].
The tumor suppressor p53 is a well known regulator of cell
division and apoptosis and curcumin has been shown to induce
apoptosis in a p53-dependent fashion [10]. Importantly, one of the
mechanisms via which p53 is thought to induce apoptosis is by
direct activation of Bax [11]. The serine/threonine kinase
glycogen synthase kinase-3 b (GSK-3b) is a multifaceted enzyme
that has been shown to interact directly with p53 and to promote
p53-dependent apoptosis thus stimulating the mitochondria-
mediated intrinsic apoptotic pathway [12,13]. Consequently,
inhibitors of GSK-3b offer protection from intrinsic apoptosis.
The mitochondrial release of apoptogenic factors is an
important but poorly understood mechanism. Several of the
proteins that are released from the mitochondrial intermembrane
space after MOMP have an anti-apoptotic role e.g. HTRA2/Omi
and SMAC/Diablo [14], whereas others are pro-apoptotic, such
as cytochrome c, apoptosis inducing factor (AIF) and endonuclease
G (EndoG) [15]. The release of large apoptogenic factors from the
mitochondria remains controversial, since the pore size of PTPC
only permits the release of molecules of ,13 kDa, like cytochrome
c [9]. Alternatively, Bax is known to oligomerize and thus form
pores, called mitochondrial apoptosis-induced channel (MAC), in
the outer mitochondrial membrane that allows for the release of
large (.2 MDa) molecules [16,17]. Furthermore, it was recently
shown that curcumin and other flavonoids induce ceramide
synthesis and that ceramides have been implicated in apoptosis via
the formation of channels in the outer mitochondrial membrane,
which enables the release of large mitochondrial proteins [18–20].
Data on the exact mitochondrial localization of AIF are
conflicting. Some studies show that soluble AIF is present in the
intermembrane space and therefore MOMP alone would be
sufficient to release this form of AIF from the mitochondria [21].
Other studies postulate that AIF is inserted in the inner
mitochondrial membrane and therefore needs to be cleaved first,
by caspases or calpains, followed by MOMP, to efflux from the
mitochondrion [22]. Following mitochondrial release, AIF trans-
locates to the nucleus via its nuclear localization signal, where it
contributes to chromatin condensation and high molecular weight
DNA fragmentation [21]. Furthermore, release of AIF from
mitochondria triggers another hallmark of apoptosis, the exposure
of phosphatidylserine (PS) on the extracellular side of the cell
membrane [21]. The role of EndoG in caspase-independent
apoptosis is largely unknown but unlike AIF, translocation of
EndoG to the nucleus results in low molecular weight DNA
fragmentation, similar to caspase-mediated DNA fragmentation
[23].
We have recently demonstrated that curcumin induced ROS-
mediated apoptosis in dermal fibroblasts, which could be inhibited
by antioxidant treatment or induction of heme oxygenase [1].
Here, we aimed to unravel the mechanism underlying this
apoptotic process and we show that curcumin-induced apoptosis
depends on mitochondrial ROS-formation and the translocation
of AIF from the mitochondrion to the nucleus and is independent
of caspase-activity. AIF translocation and subsequent apoptosis
could be blocked by N-acetyl cysteine and the VDAC-inhibitor
DIDS, but not by the specific PTPC-inhibitor cyclosporin A.
Inhibition of VDAC reduced both mitochondrial translocation of
Bax and ceramide-induced fibroblast apoptosis. Taken together,
our data shows that the release of apoptogenic factors by curcumin
from mitochondria involves VDAC, Bax and ceramides, suggest-
ing that the composition of the AIF-releasing channel is possibly
much more complex than previously thought.
Results
Curcumin-induced apoptosis is not mediated by caspase
activity
We investigated whether curcumin-induced apoptosis was
mediated by caspases. Although high levels of pro-caspase-3 were
detected by Western blot, we were unable to detect the active form
of caspase-3 protein or a reduction in band intensity of pro-
caspase-3 after curcumin treatment (results not shown). In
addition, curcumin did not induce caspase-3/7 activity in
fibroblasts, whereas the apoptosis-inducing agents cisplatin and
staurosporin increased caspase-activity significantly (both p,0.01,
figure 1A). Moreover, curcumin-induced apoptosis (25 mM) was
not blocked by co-incubation with the pan-specific caspase activity
inhibitor z-FAD-fmk (figure 1B). There was even a significant
decrease in the percentage of living cells, which was accompanied
by an increase in early apoptotic cells in the curcumin+z-FAD-fmk
group, compared to the curcumin group (p,0.001). Treatment
with the caspase-inhibitor alone had no effect on cell viability.
Absence of caspase activity was confirmed by the finding that
curcumin treatment did not result in internucleosomal low
molecular weight DNA damage (DNA laddering, results not
shown).
Curcumin treatment induces Hsp70 expression and
translocation
Since Hsp70 is an inhibitor of caspase-mediated apoptosis we
investigated whether its expression was affected by curcumin
treatment. In unstimulated cells Hsp70 was mainly localized in the
cytoplasm and some cells showed a spotted pattern in the nucleus
(Figure 2A). After 24 hours of curcumin-treatment (25 mM)
fibroblasts showed an increase in Hsp70 expression both in the
cytoplasm and nucleus (Figure 2B). Quantification of Hsp70
specific bands on Western blot showed that after curcumin
treatment expression was ,4 times higher than in untreated
controls (Figure 2D). Thus, curcumin induced the expression of
Hsp70, a protein which is possibly involved in the inhibition of
caspase activity.
High molecular weight (HMW) DNA fragmentation
Besides internucleosomal caspase-mediated DNA damage,
HMW DNA damage has also been described during apoptosis.
Therefore, we investigated if curcumin treatment resulted in
HMW DNA damage via single cell DNA electrophoresis (Comet
assay). Figure 3A clearly shows that curcumin treatment resulted
in a significantly increased comet tail length, which is a direct
measure for HMW DNA damage (average tail length of 59 pixels
in the untreated group vs 138 pixels in the curcumin-treated
group, p,0.001). Figure B and C are representative pictures of the
untreated and 25 mM curcumin group, respectively. Curcumin
AIF Efflux from Mitochondria
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fibroblasts.
ROS assay
We have previously shown that curcumin induces ROS
formation and that antioxidant treatement could fully inhibit
curcumin-induced apoptosis [1]. Here, we investigated the cellular
origin of ROS formation. Figure 4 shows that 25 mM curcumin
significantly induces ROS formation as shown by the increased
fluorescent signal compared to untreated cells (p,0.001). After
blocking mitochondrial ROS-production by the protonophore
FCCP, the fluorescent signal in the curcumin treated cells was
significantly lowered (p,0.001), indicating that curcumin-induced
ROS formation is predominantly mediated by mitochondria.
However, since the signal in the curcumin+FCCP group was still
significantly higher than in the untreated situation without FCCP
(p,0.001), curcumin also seems to induce ROS formation
independent from mitochondria.
Curcumin induces p53 expression
It is well known that activation of the tumor suppressor p53 can
induce apoptosis and therefore we studied whether p53 was
involved in curcumin-induced fibroblast apoptosis. Figure 5A+B
shows that after 8 hours of curcumin stimulation p53 protein
expression was increased 4 fold (p,0.05), compared to unstimu-
lated cells. Already after 4 hours and up to 24 hours following
stimulation with curcumin the expression of p53 was elevated,
although not statistically significant. Thus, curcumin induces
protein expression of the proapoptotic factor p53.
GSK-3b inhibitors block curcumin-induced apoptosis
Inhibitors of GSK-3b can protect cells from apoptosis [13] and it
h a sb e e ns h o w nt h a tp 5 3i sad i r e c ts u b s t r a t eo fG S K - 3 b activity [12].
Therefore, we tested if inhibition of GSK-3b-activity affected
curcumin-induced apoptosis. Both pharmacological inhibitors of
GSK-3b-activity, lithium and BIO-Acetoxime, were able to signifi-
cantly increase the percentage of living cells to 65% and 72%,
respectively, compared to 51% in curcumin-treated cells (figure 6A+B,
both p,0.001). Correspondingly, the percentage of apoptotic cells
was significantly decreased to 18% and 27% in the groups were GSK-
3b was inhibited, compared to 42% after curcumin treatment only
(both p,0.001, figure 6A+B). These results indicated that GSK-3b-
activity mediates curcumin-induced apoptosis.
Curcumin induces translocation of Bax
A well known down-stream target of p53-activity is the pro-
apoptogenic factor Bax [11,24] and, moreover, Bax has been
implicated in the formation of mitochondrial channels that are
involved in the release of apoptogenic proteins. Therefore, we
studied cellular localization of Bax during curcumin-induced
apoptosis. Figure 7A–C shows that in the untreated group, Bax
has a diffuse cytoplasmatic localization outside the mitochondria
since the mitochondria-specific protein MnSOD did not colocalize
with Bax. However, after curcumin treatment mitochondria
gathered around the nucleus and Bax was translocated to the
mitochondria, as indicated by the co-localization with MnSOD
(figure 7D–F). This showed that curcumin induced the transloca-
tion of the pro-apoptogenic factor Bax to the mitochondria.
Translocation of Apoptosis Inducing Factor (AIF)
A mechanism to explain HMW DNA damage and phospha-
tidylserine flip-flop in a caspase-independent fashion is transloca-
tion of AIF from mitochondria to the nucleus [21,25]. Our cellular
fractionation studies showed that after curcumin treatment
significantly more nuclear AIF was found than in untreated cells
(p,0.05, figure 8A–B). A specific mitochondrial protein marker
was shown not to be present in the nucleus after curcumin
treatment, indicating that the fractionation procedure was not
confounded by cross contamination (Figure 8C). Furthermore, our
immunocytochemistry results clearly showed that in untreated
cells AIF was located in the cytoplasm and not the nucleus
(figure 8G), whereas after addition of curcumin a time-dependent
increase of AIF expression in the nucleus was observed, to reach
maximum levels after 24 hours (figure Figure 8D–F). In line with
our previously published results the antioxidant N-acetyl cysteine
was able to completely inhibit AIF translocation (Figure 8H) [1].
In conclusion, curcumin causes nuclear translocation of the
mitochondrial pro-apoptotic factor AIF.
Figure 1. Curcumin-Induced Apoptosis is not Mediated by
Caspase Activity. A). Cells were treated for 24 hours with 25 mM
curcumin or were left untreated. As a positive control cells were treated
with 150 mM cisplatin or 2 mM staurosporin. Caspase-3 and -7 activity
was measured using a fluorescence based commercial assay (see M&M).
The fluorescence values in the untreated group were set at 100% and
the other values were normalized accordingly. Shown are the
mean6SD from 3 independent experiments, *=p,0.05 B). Cells were
treated with 25 mM curcumin in the presence or absence of the
caspase-activity inhibitor z-FAD-fmk (100 mM). Negative controls
included untreated cells and cells treated only with z-FAD-fmk. After
24 hours, all cells were collected and stained with Annexin-V-FITC and
propidium iodide and quadrant analysis after flow cytometry was
performed. Shown are the mean6SD of the living, early and late
apoptotic cell fractions from 3 independent experiments, ***=p,0.001
compared to 25 mM curcumin.
doi:10.1371/journal.pone.0006688.g001
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The release of AIF indicated that curcumin rendered the outer
mitochondrial membrane permeable to proteins. We investigated
if the permeability of the inner membrane was also affected by
quantifying mitochondrial accumulation of the mitochondria-
specific dye TMRE, an indicator of membrane potential loss.
Figure 9 shows that there was no difference between the
accumulation of TMRE in mitochondria of curcumin-treated
cells and untreated cells. As a positive control, we confirmed that
treatment of TMRE-labeled cells with the mitochondrial proto-
nophore FCCP resulted in a lower fluorescence caused by the
depolarization of the membrane potential. In unlabelled cells no
fluorescent signal was observed (Figure 9). Therefore, curcumin
did not affect the permeability of the inner membrane.
Inhibition of AIF translocation
Several mechanisms have been described to be involved in the
release of AIF from mitochondria. Our results with the pan-
specific caspase-inhibitor rule out a role for caspases in AIF release
during curcumin-induced fibroblast apoptosis (figure 1B). PARP-
activity is also not involved in the release of AIF since co-
incubation of curcumin with the specific PARP-inhibitor DPQ did
not affect curcumin-induced apoptosis (Table 1).
The anion exchanger and channel inhibitor DIDS also inhibits
the PTPC by blocking VDAC. Figure 10 clearly shows that
treatment with 500 mM DIDS potently blocked curcumin-induced
apoptosis (Figure 10C+D and I). The percentage of living cells
significantly increased from 53% in the curcumin-treated group to
75% in the curcumin+DIDS group (p,0.001), whereas DIDS
alone had no significant effect on cell survival (Figure 10B+I).
Correspondingly, the early apoptotic cells decreased significantly
from 44% in the curcumin group to 22% in the curcumin+DIDS
group (P,0.01). Next, we investigated whether DIDS provided
protection by abrogation of curcumin-induced nuclear AIF
translocation. The data presented in figure 10E–H confirmed
that AIF localization in the curcumin+DIDS group was mainly
cytoplasmic and not nuclear, which was comparable to the
untreated situation.
To test if DIDS acted through inhibition of chloride channels
we measured the effect of the specific chloride channel inhibitor
Figure 2. Curcumin Induces Hsp70 Protein Expression. A–C) Fibroblasts were seeded on diagnostic microscope slides and treated with 25 mM
curcumin or were left untreated. After 24 hours, cells were fixed and permeabilized and subsequently stained using a specific Ab against Hsp70.
Detection was done via an Alexa-488 labeled secondary Ab. As a negative control the primary Ab was replaced with PolyIgG. A) untreated cells, B)
25 mM curcumin, C) Untreated cells IgG control. D) Cells were treated with 25 mM curcumin or were left untreated. After 24 hours cells were lysed and
proteins were separated by SDS-PAGE and blotted onto nitrocellulose membranes. Blots were incubated with Abs against Hsp70 and b-actin (as a
loading control) and the appropriate fluorescently labeled secondary Abs. Fluorescence of the specific protein bands was determined using the
Odyssey Infrared Imaging System. Shown are the mean6SD of the band intensities of Hsp70 corrected for b-actin from 3 independent experiments,
*=p,0.05.
doi:10.1371/journal.pone.0006688.g002
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induced apoptosis but rather co-treatment of curcumin with NPPB
significantly augmented apoptosis from 52% living cells in the
curcumin group to 32% in the combination group (p,0.01,
Table 1). These results suggest that chloride channels were not
involved in the translocation of AIF during curcumin-induced
apoptosis but that a role for the anion channel VDAC could still
be possible.
Combined, these data suggest that AIF was released from the
mitochondrial intermembrane space via the PTPC. To further test
this possibility we co-treated curcumin-stimulated cells with the
PTPC inhibitor, cyclosporin A (CsA) [26]. Surprisingly, co-
incubation of CsA and curcumin did not result in a decrease of
early apoptotic cells compared to curcumin alone, 56% versus
52% respectively, whereas cisplatin-induced apoptosis was signif-
icantly inhibited by CsA (Table 1). These results rule out the
PTPC as the AIF releasing pore.
Next, we tested if DIDS affected translocation of Bax, since Bax
is known to interact with VDAC and create pores in the
mitochondrial outer membrane. Indeed, treatment with curcumin
in combination with DIDS not only blocked apoptosis and
perinuclear migration of mitochondria but also prevented Bax
translocation to the mitochondria (Figure 7G–I), whereas DIDS
Figure 3. Curcumin Induces HMW DNA Damage. Cells were
treated for 72 hours with 25 mM curcumin or were left untreated. HMW
DNA damage was studied using the CometAssay Reagent kit. Cells were
resuspended in LMAgarose the mixture was placed on to CometSlides.
Next, cells were lysed and DNA was released and allowed to unwind.
After electrophoresis, slides were fixed and nuclei were stained with
SYBR Green. Positive nuclei were analyzed using a fluorescence
microscope and a filter for FITC. Nuclei were chosen in a random
fashion by a blinded observer using a CCD-camera and a computer
monitor. Comet tail length was quantified by a blinded observer using
ImageJ image analysis software. A) Shown is a scatter plot were the tail
length of the comet of all positive nuclei in the untreated and
curcumin-treated group is depicted of 3 independent experiments. The
solid horizontal line represents the mean. B) representative picture of a
nucleus of an untreated cell. C) representative picture of a nucleus of a
curcumin-treated cell, ***=p,0.001.
doi:10.1371/journal.pone.0006688.g003
Figure 4. Curcumin-induces ROS formation. Cells were labelled
with the ROS-specific labeling dye H2DCFDA before they were treated
for 45 min with 25 mM curcumin or not treated. To block mitochondrial
ROS production the uncoupler agent FCCP was used. After treatment,
cells were lysed and fluorescence was determined at excitation 485 nm
and emission 520 nm. For each treatment unlabelled cells served as the
negative control. Shown are the mean6SD of 3 independent
experiments. ***=p,0.001, **=p,0.01 and
###=p,0.001 compared
to untreated - FCCP.
doi:10.1371/journal.pone.0006688.g004
Figure 5. Curcumin induces p53 expression. A). Cells were treated
with 25 mM curcumin for the indicated time points before cells were
lysed and proteins were separated by SDS-PAGE and blotted onto
nitrocellulose membranes. Blots were incubated with Abs against p53
and b-actin (as a loading control) and the appropriate fluorescently
labeled secondary Abs. B). Fluorescence of the specific protein bands
was determined using the Odyssey Infrared Imaging System. Shown are
the mean6SD of the band intensities of Hsp70 corrected for b-actin
from 3 independent experiments, *=p,0.05 compared to 0 h.
doi:10.1371/journal.pone.0006688.g005
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quently, DIDS blocked curcumin-induced apoptosis, inhibited
mitochondrial Bax translocation and prevented the release of AIF
from mitochondria.
Taken together, our results indicate that Bax interacted with
VDAC to generate a pore that is sensitive to DIDS, insensitive to
CsA, and permits the efflux of AIF.
Ceramides
Interestingly, curcumin has been shown to induce ceramide
synthesis and ceramides are able to form pores in mitochondrial
membranes, thereby allowing for the release of mitochondrial
proteins such as AIF. We decreased ceramide levels by inhibition
of de novo ceramide synthesis via myriocin and fumonisin.
However, neither co-incubation of curcumin and the inhibitors
nor pretreatment of the cells with inhibitors prior to curcumin
treatment resulted in inhibition of curcumin-induced apoptosis
(Table 1). Also, blocking the direct formation of ceramide from
sphingomyelins by inhibiting sphingomyelinase with manumycin
did not rescue fibroblasts from curcumin-induced apoptosis
(Table 1). All substances tested were used at a concentration that
did not affect cell viability (data not shown). However, we could
not exclude the possibility that ceramides present in the
mitochondrial membrane were rearranged after treatment with
curcumin. Therefore, we studied whether exogenously adminis-
tered ceramides could induce fibroblast apoptosis. Figure 11A–D
shows light microscopic images indicating that 100 mM ceramide
caused fibroblast apoptosis and, interestingly, co-treatment with
DIDS resulted in protection, as judged from the considerable
higher number of attached fibroblast-like cells. Moreover,
figure 11E, clearly demonstrates that ceramides significantly
decreased the percentage of living cells, which was accompanied
by a significant increase in apoptotic cells, compared to untreated
and DIDS-treated cells (all p,0.001). Furthermore, co-treatment
of ceramides and DIDS significantly improved the percentage of
living cells and decreased the percentage of late apoptotic and
necrotic cells (all p,0.001). The induction of apoptosis by
ceramides was shown to be independent of caspase-activity
(Figure 11F). Taken together, we cannot exclude a role for
ceramides in the formation of pores, possibly in conjunction with
VDAC and Bax, that allow for the release of AIF from
mitochondria during curcumin-induced apoptosis.
Discussion
The mechanism by which curcumin induces apoptosis in non-
transformed cells has been linked to both caspase-dependent and –
independent pathways. In our model no active caspase-3 or-7
could be detected and the pan-specific caspase-inhibitor z-FAD-
fmk did not affect curcumin-induced apoptosis. Piwocka et al.
previously demonstrated in Jurkat cells that curcumin induced
caspase-independent apoptosis, which resulted in HMW DNA
damage similar to our data, but mitochondria were not involved.
[27,28]. However, in a later study also in Jurkat cells, the same
group described that curcumin can also induce apoptosis in a
caspase-dependent fashion [29]. Similarly, curcumin-induced
apoptosis in human renal Caki cells has been shown to depend
on ROS formation and caspase activity, since antioxidants and
caspase inhibitors blocked curcumin-induced DNA fragmentation
and apoptosis [30]. Recently, it was found in murine fibroblasts
that curcumin induces both caspase-dependent and caspase-
independent apoptosis [10]. Similar to our model, in this study
curcumin stimulated ROS formation, which led to the release of
AIF from the mitochondria. However, curcumin treatment also
caused release of cytochrome c and the subsequent activation of
caspase-3 and PARP, which could be blocked by the caspase-
inhibitor z-FAD-fmk.
In our model no caspase-activity was detected despite high levels
of pro-caspase-3 protein in both untreated and curcumin-treated
groups (data not shown), suggesting that the caspase-3-activating
step was inhibited. Hsp70 is known to inhibit several steps in the
caspase-dependent apoptosis pathway including apoptosome
formation and the activation of caspase-8, both of which are
involved in the activation of caspase-3 [31,32]. It is tempting to
speculate that the increase in Hsp70 protein expression after
curcumin treatment is involved in the inhibition of the caspase-
Figure 6. GSK-3b-inhibitors block curcumin-induced apoptosis.
Cells were treated with 25 mM curcumin in the presence or absence of
the GSK-3b activity inhibitors LiCl (A) or BIO-Acetoxime (B). Negative
controls included untreated cells and cells treated only with z-FAD-fmk.
After 24 hours, all cells were collected and stained with Annexin-V-FITC
and propidium iodide and quadrant analysis after flow cytometry was
performed. Shown are the mean6SD of the living, early and late
apoptotic cell fractions from 3 independent experiments,
***=p,0.001, **=p,0.01 and *=p,0.05 compared to 25 mM
curcumin.
doi:10.1371/journal.pone.0006688.g006
AIF Efflux from Mitochondria
PLoS ONE | www.plosone.org 6 August 2009 | Volume 4 | Issue 8 | e6688dependent pathway in our model, but this needs further
investigation. On the other hand, overexpression of Hsp70 has
also been described to inhibit AIF and Bax translocation [33,34].
Obviously, in our apoptosis model the translocation of AIF and
Bax was not inhibited by increased Hsp70 expression, probably
because in our model the endogenous expression of Hsp70 was
increased rather than artificially overexpressed by transduction.
We and others have prevously shown that curcumin induces the
production of ROS and that inhibition of ROS generation
prevents curcumin-induced apoptosis [1,10]. Here, we investigat-
Figure 7. Curcumin Induces Bax Translocation. Fibroblasts were seeded on diagnostic microscope slides and treated with 25 mM curcumin,
500 mM DIDS, the combination, or were left untreated. After 24 hours, cells were fixed and permeabilized and subsequently stained using a specific
Ab against Bax A,D,G,J) and the mitochondrial protein MnSOD B,E,H,K). Detection was done via Alexa-488 for MnSOD (green) and Alexa-594 for Bax
(red) labeled secondary Ab. C,F,I,L) are overlays of green and red images. A–C) untreated, D–F) 25 mM curcumin, G–I) 25 mM curcumin+500 mM DIDS,
J–L) 500 mM DIDS. PolyIgG controls for M) Bax and N) MnSOD.
doi:10.1371/journal.pone.0006688.g007
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24 hours cells were lysed and nuclear and cytoplasmatic proteins were isolated using a commercial kit. A) Identical protein concentrations were
loaded and separated by SDS-PAGE and blotted onto nitrocellulose membranes. Blots were incubated with Abs against AIF and a mito-marker (as a
control for protein separation) and the appropriate fluorescently labeled secondary Abs. The fluorescence of the specific protein bands was
determined using the Odyssey Infrared Imaging System. Shown is the result of a representative of 3 independent experiments. B) Mean6SD of the
band intensities of AIF from 3 independent experiments. C) Mean6SD of the band intensities of mito-marker from 3 independent experiments. D–I)
Fibroblasts were seeded on diagnostic microscope slides and treated with 25 mM curcumin or were left untreated. After 24 hours, cells were fixed
and permeabilized and subsequently stained using a specific Ab against AIF. Detection was done via an Alexa-488 labeled secondary Ab. D) 6 hours
25 mM curcumin, E) 16 hours 25 mM curcumin, F) 24 hours 25 mM curcumin, G) untreated cells, H) 24 hours 25 mM curcumin+6 mM NAC, I) 24 hours
6 mM NAC, *=p,0.05 compared to nuclear AIF in the untreated group.
doi:10.1371/journal.pone.0006688.g008
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had a cytoplasmatic origin. By using the mitochondrial uncoupler
FCCP, which prevents mitochondrial ROS generation, we
detected a significantly decreased ROS formation at 25 mM
curcumin, indicating that mitochondria are predominantly
involved in curcumin-induced ROS formation. These data
correspond to previously published results, where lowering the
bioenergetic capacity of mitochondria suppressed curcumin-
induced cytotoxicity in human cutaneous squamous cell carcino-
ma cells [35]. However, since the levels of ROS in the
curcumin+FCCP group, were still significantly elevated above
the level in untreated cells, curcumin also seems to induce
mitochondria-independent ROS formation.
Apoptosis is often controlled by the redox-sensitive proapoptotic
factor p53 and curcumin is known to induce p53-dependent
apoptosis in several cell types [36]. Besides its obvious effects on
transcription of numerous proapoptotic factors, p53 is also known
to directly activate Bax, which leads to mitochondrial permeabi-
lization and subsequent apoptosis [11]. Our results are in line with
these data since we show that in dermal fibroblasts curcumin
induces the expression of p53, which is followed by mitochondrial
tranlocation of Bax. Possibly, p53 forms a complex with Bax in the
mitochondrial membrane as suggested by others [35]. The extend
of the non-transcriptional activities of p53 in our model is under
current investigation. The pro-apoptotic signaling enzyme GSK-
3b is associated with mitochondria-mediated apoptosis since
mitochondrial GSK-3b activity is increased during intrinsic
apoptosis [36]. Furthermore, it has been shown that GSK-3b is
able to bind p53 and that inhibition of GSK-3 activity blocks p53-
mediated apoptosis [12]. Indeed, in our apoptosis model inhibition
of GSK-3b activity by two structurally different inhibitors, rescued
cells from curcumin-induced apoptosis, which is in line with a
GSK-3b - p53 interaction. So, curcumin induces p53 expression,
which in concert with GSK-3b, and possibly as one large protein
complex, causes mitochondrial translocation of Bax.
Although a lot of research on AIF has been performed it still
remains unclear if it is cleaved from the inner membrane or
present in a soluble form in the intermembrane space. (ADP-
ribose) polymerase-1 (PARP) activity has been shown to be an
important activator of caspase-independent apoptosis and involved
in the release of AIF, which eventually leads to high molecular
weight DNA fragmentation, MOMP and the release of cyto-
chrome c [37]. But in our hands inhibition of PARP activity by its
specific inhibitor DPQ did not block curcumin-induced apoptosis,
indicating that PARP activity did not play a role in the release of
AIF. Alternatively, it is often assumed that caspase activity is
essential for cleaving AIF from the inner mitochondrial mem-
brane, causing the protein to become soluble in the intermem-
Figure 9. Curcumin does not Cause Mitochondrial Inner
Membrane Depolarization. Fibroblasts were treated with 25 mM
curcumin or were left untreated. After 24 hours, cells were labeled for
30 minutes with 0.1 mM of the fluorescent dye tetramethylrhodamine
ethyl ester (TMRE), which accumulates in mitochondria. As a negative
control cells were not labeled. To check if the cells were correctly
labeled the protonophore FCCP was added, which causes mitochon-
drial membrane depolarization. Fluorescence was determined using
flow cytometry using channel FL2. Grey peak=untreated cells, thick
black line=25 mM curcumin, thin black line=FCCP treatment of
untreated TMRE-labeled cells, dashed line=unlabelled cells. M1
represent negatively labeled cells, M2 represents positively labeled cells.
doi:10.1371/journal.pone.0006688.g009
Table 1. Effect of specific inhibitors of various intracellular
pathways on curcumin-induced apoptosis.
Treatment
a Living
b Early Apoptotic
b
mean6SD mean6SD
Untreated 96624 62
25 mM Curcumin 40695 7 68
25 mM Curcumin+30 mM DPQ
c 30610 6669
25 mM Curcumin 52654 1 63
25 mM Curcumin+50 mM NPPB
d 32612
** 5369
*
25 mM Curcumin 43645 2 61
25 mM Curcumin+2.5 mM Cyclosporin A
e 40695 6 614
200 mM Cisplatin 28664 3 67
200 mM Cisplatin+2.5 mM Cyclosporin A
e 4563
** 3262
*
25 mM Curcumin 38685 8 65
25 mM Curcumin+5 mM Myriocin
f 32626 5 64
25 mM Curcumin+5 mM Myriocin
f (Pre)
g 34646 3 62
25 mM Curcumin 42614 54611
25 mM Curcumin+100 mM Fumonisin
f 39615 56611
25 mMC u r c u m i n +25 mM Fumonisin
f (Pre)
g 43625 50617
25 mM Curcumin 47613 49610
25 mM Curcumin+100 mM Manumycin
f 47614 49611
25 mMC u r c u m i n +100 mM Manumycin
f (Pre)
g 45614 51611
aCells were treated for 24 hours as indicated and subsequently stained with
Annexin-V-FITC and propidium iodide and quadrant analysis after flow
cytometry was performed.
bShown are the mean % 6standard deviation (SD) from the living and early
apoptotic cell fractions from 3 independent experiments.
cDPQ was used as an inhibitor of PARP activity.
dNPPB was used as a specific inhibitor of chloride channels.
eCyclosporin was used as a specific-inhibitor of the PTPC.
fInhibitors of specific steps in ceramide synthesis.
g‘‘pre’’ indicates that the inhibitor was given to the cells 24 hours prior to
curcumin.
**=p,0.01 and
*=p,0.05.
doi:10.1371/journal.pone.0006688.t001
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that in the presence of the pan-specific caspase inhibitor z-FAD-
fmk, AIF is still able to translocate to the nucleus, which argues
against a role for caspases in the release of AIF [21,37]. Calpains
are also thought to cleave AIF from the inner membrane [22] but
since z-FAD-fmk is known to inhibit calpain activity it is likely that
in our model curcumin-induced apoptosis relies on soluble AIF
present in the mitochondrial intermembrane space.
DIDS is a non-selective inhibitor of anion exchangers and
channels and it can prevent apoptosis by a yet unknown
mechanism. DIDS has been described to inhibit apoptosis via
prevention of cell volume decrease by blocking volume sensitive
outwardly rectifying (VSOR) channels. However, in our flow
cytometry studies curcumin-treatment did not change the forward
scatter of cells, indicating that cell size was unaltered (data not
shown). Another likely target for DIDS in the inhibition of
apoptosis is VDAC, which is located in the outer mitochondrial
membrane. It was recently reported that DIDS prevented
cisplatin-induced cell death by inhibiting conformational activa-
tion of Bax, which was shown to depend on VDAC [41]. In
another recent study, DIDS attenuated staurosporin-induced
apoptosis in cardiomyocytes partly by preventing the translocation
of Bax, similar to our findings, but in this study apoptosis was
mediated by cytochrome c and caspase activity and not by AIF
[42]. How DIDS influences the release of mitochondrial proteins
requires further investigation.
The release of large apoptogenic proteins from the mitochon-
drial intermembrane space during apoptosis remains controversial.
The PTPC consists of the anion channel VDAC, ANT and CypD
and has long been implicated in this process but its pore size is too
small to allow passage of AIF [43]. Since we observed no change
in membrane potential after curcumin stimulation, ANT, which is
Figure 10. DIDS Inhibits Curcumin-Induced Fibroblast Apoptosis and AIF Translocation to the Nucleus. Cells were seeded on diagnostic
microscope slides and treated with 25 mM curcumin, 500 mM DIDS, the combination, or were left untreated. A–D) Cell morphology after 24 hours of
treatment. E–H) Immunocytochemistry of AIF. Cells were fixed and permeabilized and subsequently stained using a specific Ab against AIF. Detection
was done via an Alexa-488 labeled secondary Ab. A+E) untreated, B+F) 500 mM DIDS, C+G) 25 mM curcumin, D+H) 25 mM curcumin+500 mM DIDS. I)
Flow cytometry data. Cells were collected and stained with Annexin-V-FITC and propidium iodide and quadrant analysis after flow cytometry was
performed. Shown are the mean6SD from the living, early and late apoptotic cell fractions from 3 independent experiments, ***=p,0.001 and
**=p,0.01 compared to 25 mM curcumin.
doi:10.1371/journal.pone.0006688.g010
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involved. Also the potent and specific CypD-inhibitor CsA had no
effect on curcumin-induced apoptosis, further ruling out the
involvement of the PTPC. The pro-apoptotic protein Bax can
interact with VDAC and has been shown to be essential for the
release of AIF [8,22]. However, the pores formed by this
interaction are only permeable to proteins of ,13 kDa like
cytochrome c and not the much larger AIF protein (57 kDA) [9].
Bax by itself can also oligomerize and form supramolecular
openings that would allow for the release of AIF [17,44]. The
strong rescuing effect of DIDS on curcumin-induced apoptosis as
observed in this study, however, makes it hard to envision a
channel without a role for VDAC. It is intriguing how DIDS, a
drug thought to act on mitochondrial VDAC, prevents the
translocation of Bax from cytoplasm to mitochondria. DIDS
perhaps binds to VDAC, which is thought to act as an anchor
point, in such a way that the interaction with Bax is hindered. On
the other hand, inhibition of VDAC by DIDS could block an as
yet unknown signal originating from mitochondria, which triggers
Bax translocation.
Curcumin and other flavonoids increase ceramide levels and
ceramides are known to induce apoptosis [19,20]. Combined with
the fact that ceramides can generate large pores in mitochondrial
membranes [45,46], this led us to investigate whether ceramides
could play a role in curcumin-induced apoptosis. Inhibition of de
novo synthesis and inhibition of the ceramide-generating enzyme
sphingomyelinases did not significantly block curcumin-induced
apoptosis, indicating that ceramides either are not involved or are
sufficiently present in mitochondrial membranes. The addition of
exogenous ceramides indeed resulted in fibroblast apoptosis and,
strikingly, this form of apoptosis was not only independent of
caspase-activity but could also be inhibited by DIDS in a similar
fashion as curcumin-induced apoptosis, therefore signifying a role
for VDAC in ceramide-induced apoptosis. These data are
suggestive for a concerted action of ceramides, VDAC and
possibly Bax in the formation of channels in the outer
mitochondrial membranes to release AIF.
The mechanism via which curcumin induces apoptosis seems to
be complex and dependent on the cell type studied and caspase-
activity may be a confounding factor in the identification of the
exact mechanism how apoptogenic factors are released from
mitochondria. We show in our model that curcumin induces
predominantly the formation of mitochondria-mediated ROS.
Curcumin-induced apoptosis is totally independent from caspase-
activity, and, more specifically, relies on AIF release, since we
observed nuclear translocation of AIF and HMW DNA damage.
Inhibition of AIF translocation also blocked curcumin-induced
apoptosis. In our attempt to identify via which mechanism AIF is
released from mitochondria after curcumin stimulation we
gathered evidence that not only VDAC and Bax, but also
Figure 11. Ceramide Induces Caspase-Independent Fibroblast Apoptosis. Cells were seeded and treated with 100 mM ceramide, 500 mM
DIDS, the combination, or were left untreated. A–D) Cell morphology after 24 hours of treatment. E) Flow cytometry data. Cells were collected and
stained with Annexin-V-FITC and propidium iodide and quadrant analysis after flow cytometry was performed. Shown are the mean6SD from the
living, early and late apoptotic cell fractions from 3 independent experiments. F) Caspase-3 and -7 activity were measured using a fluorescence based
commercial assay. The fluorescence values in the untreated group were stated as 100% and the other values were normalized accordingly. Shown are
the mean6SD from 3 independent experiments, *=p,0.05 ***=p,0.001 and **=p,0.01 compared to 100 mM ceramide.
doi:10.1371/journal.pone.0006688.g011
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the release of large proteins such as AIF from the mitochondrial
intermembrane space. The unique caspase-independent apoptosis
model described here can give important clues to further research
on how apoptogenic factors are released from mitochondria.
Materials and Methods
Fibroblast culture
Human foreskin-derived fibroblasts were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) with high glucose, containing
10% fetal calf serum (MP Biomedicals, Uden, the Netherlands)
and 1% penicillin/streptomycin/amphotericin B (Invitrogen life
sciences, Breda, the Netherlands) at 37uCi na n5 %C O 2
atmosphere. Medium was refreshed every 2–3 days and when
the cells reached ,90% confluence they were subcultured using
trypsin-EDTA (Invitrogen) at a 1:3 dilution.
Western blotting
Cleavage of caspase-3, expression levels of Hsp70, p53 and the
subcellular localization of AIF was investigated by Western
blotting after 25 mM curcumin treatment and compared to
untreated cells. Subcellular localization of AIF was studied using
the NE-PER Nuclear and Cytoplasmic Extraction Reagent
(Pierce, Thermo Fisher Scientific, Etten-Leur, The Netherlands)
according to manufacturers protocol. SDS-Page and Western
blotting procedure were essentially performed as described
previously [1]. Blots were incubated for 1 hour at RT with mouse
anti-caspase-3 Ab (1:500; eBiosciences, AMDS Benelux, Malden,
The Netherlands), rabbit anti-Hsp70 (Koma Biotech Inc. via
Abcam), mouse anti-p53 (1:2500; BD Biosciences, Breda, The
Netherlands) or rabbit anti-AIF Ab (1:1000, Millipore, Amster-
dam, The Netherlands). Rabbit-anti-b-actin Ab served as a protein
loading control (1:1000, Abcam, Cambridge, UK). The quality of
cell fractionation was verified by staining for a mitochondria-
specific protein (1:500, mouse anti-mito-marker, Abcam). The
secondary antibodies used were, goat-anti-mouse Alexa Fluor 680
(1:20.000, Rockland, Heerhugowaard, the Netherlands) and goat-
anti-rabbit IRDye 800 (1:20.000 Sigma-Aldrich, Zwijndrecht, The
Netherlands). The membranes were scanned using the Odyssey
Infrared Imaging System (LI-COR Biosciences, Westburg B.V.,
Leusden, The Netherlands).
Caspase-3/7 activity assay
Fibroblasts were seeded in a 96-well plate and treated for
48 hours with different doses of curcumin, ceramide or as a
positive control with cisplatin and staurosporin, or were left
untreated (negative control). Caspase-3/7 activity was determined
by the Apo-ONE Caspase-3/7 Assay (Promega, Leiden, The
Netherlands) according to the manufacturers recommendations.
Formation of the fluorescent product of caspase activity was
measured using a Polarstar Galaxy plate reader (BMG Lab-
Technologies GmbH, Offenburg, Germany).
Comet assay
HMW DNA damage was studied using the CometAssay
Reagent kit (Trevigen, SanBio b.v., Uden, The Netherlands).
Fibroblasts were plated at 70% confluence in 6-well plates and
allowed to adhere for at least 6 hours before the cells were treated
with varying doses of curcumin for 72 hours. Cells were released
by trypsin and 10,000 cells were resuspended in 75 ml LMAgarose
and subsequently the agarose-cell mixture was placed on to
CometSlides. After incubating the slides for 30 min at 4uC to let
the agarose solidify, the slides were incubated for 60 min in lysis
buffer at 4uC to lyse the cells and release DNA. Next, slides were
transferred to a horizontal electrophoresis tray (Owl separation
system) filled with an alkaline electrophoresis buffer (300 mM
NaOH, 1 mM EDTA, pH.13) and DNA was allowed to unwind
during 30 min at 4uC. Electrophoresis was carried out at 25 V for
30 min at 4uC, after which the slides were washed three times with
neutralization buffer (0.4 M Tris-HCl, pH 7.5). CometSlides were
fixed with 100% ethanol for 10 min, air dried and DNA was
visualized using SYBR Green I solution (1:10,000 dilution in TE
buffer, 5 min at 4uC). SYBR Green positive nuclei were analyzed
using a fluorescence microscope (Leica DM RA) using a filter for
fluorescein isothiocyanate (FITC). Per treatment 38 nuclei were
chosen in a random fashion by a blinded observer using a Cohu
high-performance charge-coupled device camera and a computer
monitor. Comet tail length was quantified by a blinded observer
using ImageJ image analysis software (National Institutes of
Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/).
Measurement of Reactive Oxygen Species (ROS)
ROS formation induced by curcumin was determined as
described previously [1]. In brief, the ROS-specific labeling dye
5-(and-6)-chloromethyl-29,79-dichlorodihydrofluorescein diacetate,
acetyl ester (H2DCFDA, Invitrogen) was used to label the cells
(10 mMH 2DCFDA in Hanks’ Balanced Salt Solution (HBSS) for
15 min at 37uC). Subsequently, cells were washed once with
HBSS and treated for 45 min with 25 mM curcumin or not
treated. To study whether curcumin induced cytoplasmatic or
mitochondrial ROS production, we used the uncoupler agent
carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP, In-
vitrogen), which disrupts ATP synthesis and hence mitochondrial
ROS production. Cells were pretreated for 10 min with 1 mM
FCCP prior to labeling with H2DCFDA and also during the
labeling and treatment steps 1 mM FCCP was present. Afterwards,
cells were washed with HBSS and fluorescence was determined
using a Fluostar Galaxy fluorometer at excitation 485 nm and
emission 520 nm (BMG Lab Technologies, Offenburg, Germany).
For each treatment unlabelled cells served as the negative control.
Determination of Mitochondrial Membrane Potential
To investigate if curcumin induced loss of inner mitochondrial
membrane potential we determined mitochondrial accumulation
of the fluorescent dye tetramethylrhodamine ethyl ester (TMRE,
Invitrogen) in curcumin-treated and untreated fibroblasts. To
check if the cells were correctly labeled the mitochondrial
protonophore FCCP (p-trifluoromethoxy carbonyl cyanide phenyl
hydrazone, Invitrogen) was added, which induces mitochondrial
membrane depolarization. As a negative control, cells were not
labeled. After treatment cells were collected and labeled for
30 minutes with 0.1 mM TMRE (Invitrogen). Next, cells were
washed with PBS and fluorescence was determined using flow
cytometry (FACScan, BD Biosciences) using channel FL2.
Modulation of curcumin-induced apoptosis
We investigated which factors are involved in curcumin-induced
apoptosis. To test whether caspases are involved in mitochondrial
release of AIF during curcumin-induced apoptosis, fibroblasts were
treated with 25 mM curcumin in the presence or absence of the pan-
specific caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp fluoro-
methylketone (z-VAD-fmk, 100 mM, R&D Systems, Abingdon,
UK). LiCl (80 mM, Sigma-Aldrich) and BIO-Acetoxime (2 mM,
Calbiochem, San Diego, CA, USA) were used to study their
inhibitory effect on GSK-3b-activity. The specific inhibitor DPQ
(3,4-Dihydro-5-[4-(1-piperidinyl)butoxyl]-1(2H)-isoquinolinone, Sig-
ma-Aldrich, 30 mM) was used to block PARP-activity. The effect of
AIF Efflux from Mitochondria
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disulfonic acid disodium salt hydrate, Sigma-Aldrich, 500 mM) and
the specific chloride channel inhibitor NPPB (nitro -2 -(4-
phenylpropylamino) benzoic acid, Sigma-Aldrich, 50–100 mM) on
curcumin-induced apoptosis was also studied. The effect of blocking
ceramide generation on curcumin-induced apoptosis was studied by
blocking de novo synthesis of ceramide by pretreating the cells for 24–
48 hours before exposure to curcumin with different doses of
myriocin (Sigma-Aldrich, 5–50 mM) or fumonisin (Sigma-Aldrich,
50–100 mM). Direct generation of ceramide from sphingomyelins by
sphingomyelinase during curcumin-induced apoptosis was blocked
by addition of different doses of manumycin (Sigma-Aldrich, 1–
10 mM). Ceramides (Sigma-Aldrich) were added in a concentration
of 100 mM to fibroblasts to check if apoptosis was induced in the
presence or absence of 500 mM DIDS. Cyclosporin A (CsA, Sigma-
Aldrich) in a concentration of 2.5 mM was used as a blocker of the
PTPC to test if this channel was involved in curcumin-induced
apoptosis. All tested inhibitors were used at a concentration that did
not affect cell viability. Apoptosis was investigated by flow cytometry
(see below). Fibroblasts were plated at 70% confluence in6-well plates
for FACS analysis or for immunocytochemistry purposes on 12-well
diagnostic microscope slides (Cel-Line, Thermo Scientific, Braunsch-
weig, Germany) and allowed to adhere for at least6 hours before cells
were treated.
Flow cytometry
Flow cytometry analysis was used to differentiate between living,
early apoptotic, late apoptotic/necrotic and necrotic cells by
staining with Annexin V-FITC and propidium iodide (PI). After
48 hours of treatment, all cells were collected and 100,000 cells
were resuspended in 100 ml binding buffer containing Annexin V-
FITC and PI according to the manufacturers recommendations
(BioVision Inc, ITK Diagnostics b.v., Uithoorn, The Netherlands).
Next, samples were incubated for 15 min. at RT in the dark. As a
positive control for the Annexin V-FITC and PI staining,
fibroblasts fixed with 4% paraformaldehyde and permeabilized
by 0.1% saponine were used. Quantification of Annexin V-FITC
and PI binding was performed by a FACScan (BD Biosciences)
using channels FL-1 (Annexin V-FITC) and FL-3 (PI). Cellquest
Pro was used to perform quadrant analysis.
Immunocytochemistry
To study cellular localization of AIF, Hsp70, manganese
superoxide dismutase (MnSOD, mitochondrial marker) and Bax
we used immunocytochemistry. After 24 hours of treatment, cells
were washed with PBS and fixed for 15 min in 4% paraformal-
dehyde in PBS. Next, the cells were washed three times and cells
were permeabilized and aspecific epitopes were blocked for
30 min at RT with PBA (1% bovine serum albumin, 0.1%
saponin, 0.05% NaN3 in PBS) together with 2% serum of the
animal species in which the secondary antibody was generated.
Primary Ab’s rabbit anti-AIF, rabbit anti-Hsp70, rabbit anti-
MnSOD (Stressgen, via ITK Diagnostics b.v.) and mouse anti-Bax
(Abcam) were incubated for 45 min in PBA at a concentration of
5 mg/ml or as indicated by the manufacturer. As a negative
control the primary Ab was replaced by polyIgG at 5 mg/ml. After
washing three times with PBA, cells were incubated for 30 min
with the appropriate fluorescently labeled secondary Ab (Alexa
594 or Alexa 488) (Invitrogen, 1:1000 in PBA). Cells were washed
twice with PBA and once with PBS before mounting the slides
with Fluorescent Mounting Medium (DakoCytomation, Dako
Netherlands b.v., Heverlee, Belgium). Fluorescence was studied
using a fluorescence microscope (Leica DM RA) using a filter for
tetramethyl rhodamine iso-thiocyanate (TRITC) and/or FITC.
Images were taken via a Cohu high-performance charge-coupled
device camera and a computer monitor.
Statistical analysis
Statistics were performed using GraphPad Prism 4.03 software
via a One-way analysis of variance (ANOVA) followed by the
Newman-Keuls multiple comparison test when comparing 3 or
more groups. A Student’s T-test was used when comparing 2
groups. Differences between groups were stated to be statistically
significant when p,0.05. All experiments were repeated at least 3
times.
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